Patient Support Programs
Patient assistance programs can have an enormous impact on the time-to-treatment for prescribers and patients. Your ability to establish a patient assistance program strategy, especially when there are barriers to prescribing.
Our messaging playbooks contain real industry data and messaging to give you a competitive edge.
Monitor Payer Messaging Perception: Breast Cancer
In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in breast cancer.
Monitor Payer Messaging Perception: Migraine
In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in migraine.
Monitor Payer Messaging Perception: Rheumatoid Arthritis
In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in rheumatoid arthritis.
Monitor Payer Messaging Perception: Oncology Biosimilars
In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in oncology biosimilars.
Monitor Payer Messaging Perception: Atopic Dermatitis
In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in atopic dermatitis.
Monitor Payer Messaging Perception: Non-Small Cell Lung Cancer
In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in non-small cell lung cancer.
Our White Papers dive into core drug access topics and themes relevant to MMIT.
Patient Access During Pre-Launch Phases
Months before the first scripts are written, and long before revenue actuals are compared to sales forecasts, a launch brand’s patient access future has largely been determined. So why aren’t pharma teams shifting market access strategies to earlier phases of drug development?
The influence of payers and PBMs is often poorly understood. Download our white paper to learn more.
Insurer, Specialty Pharmacy Rely on Solutions from RJ Health to Price Drugs Correctly
As specialty pharmaceuticals consume an ever-larger share of healthcare benefit dollars, payers, providers and other healthcare organizations are realizing the importance of managing drugs administered under the medical benefit, which most often are specialty drugs. Download our white paper to learn more.
Read customer success stories on their journey to solve business challenges.
From Impasse to Insights: Finding a Way Forward With FormTrak
How MMIT helped a midsize pharmaceutical sales team influence prescriber behavior and overcome barriers to access.
MMIT’s Strategic Partnership: Rapid Response In Action
How MMIT’s longstanding advisory relationship with a global pharmaceutical company helped transform its portfolio strategy.
A Second-to-Market Success
Learn how a data-driven market access strategy and competitor benchmarking led to launch excellence.
Helping MarketLauncher Capture Success
Learn how MMIT and MarketLauncher helped a medtech company engage a difficult-to-reach health plan audience.
Credibility’s Competitive Advantage
Learn how RJ Health helped a niche healthcare company bolster its payer communications.
Analytics Data Helps Healthcare Services Company Complete the Picture for Providers
Learn how a healthcare services company partnered with MMIT to help support its provider network with coverage data.
Value Proposition Message Testing
Learn how a pharma company preparing for a drug launch partnered with MMIT to gain insight into the most effective messaging with payers.
Strategic Launch Report With In-Depth Interviews
Learn how a pharma company leveraged MMIT’s Strategic Launch Report combined with In-Depth Interviews to get a unique view into the market access path for its therapy.
Post-Launch Tracking Surveys
Learn how a pharma company partnered with MMIT’ to understand payer perceptions of its brand over time as competitors enter the market.
Drug Launch Planning: Using Analytics to Overcome Market Access Challenges
Learn how a small pharma company leveraged MMIT’s Analytics platform to drive its messaging with healthcare providers as it launched its first commercial product at the start of the COVID-19 pandemic.
Understanding PBM Competitive Intelligence
Take a look into how a PBM was able to gain a deeper understanding of their market potential and obtain competitive intelligence with Payer Landscape.
Streamlining the Referral Process
Take a look into how a specialty pharmacy partnered with MMIT to enhance its referral process and decrease time to therapy for patients.
Prepare For a Device Launch
Learn how a medical device company partnered with and leveraged MMIT’s Payer Landscape data.
Custom Pricing and Contracting Studies
Learn how a pharma company’s market access team leveraged MMIT’s quantitative online surveys to obtain a custom pricing and contracting study to support its drug launch.
Advisory Board Meetings
Learn how a pharma company leveraged MMIT’s advisory board service to get unique insights from payers and physician key opinion leaders (KOLs) to support its drug launch.
Systematizing Health Plan Targeting
Learn how a healthcare IT organization automated payer account identification and outreach.
Breaking Down Granular Enrollment Data
Learn how a healthcare IT organization was able to gain a deeper understanding of their market potential and obtain competitive intelligence with Payer Landscape.
Gain knowledge of industry trends and thought leadership by browsing our Meet the Expert webinar series. Watch MMIT’s webinar series at your convenience and view any of our previously recorded sessions.
MTE Session: Addressing Rebate Leakage Through Industry-Leading Data & Workflow Automation
Addressing Rebate Leakage Through Industry-Leading Data & Workflow Automation
The average mid-size pharmaceutical manufacturer spends $4 billion to $5 billion in rebates annually — but loses millions of dollars in rebate overpayments and lost productivity due to manually intensive processes to validate contracted coverage. Learn the causes of rebate leakage and how MMIT’s Contract Validation solution can provide a workflow automation platform that enables manufacturers to validate formulary positioning at scale.
MTE Session: Pathways Utilization Amidst Rising Costs of Oncology Treatments
MTE Session: Pathways Utilization Amidst Rising Costs of Oncology Treatments
For oncology drug manufacturers, it’s crucial to understand what third party pathways are, who creates and uses them, and how and why adherence rates to pathways vary. You’ll also learn how a product’s placement on pathways affects its utilization and uptake, and ultimately, patient’s access to life saving therapies.
MTE Session: Understanding the Impact of Humira Biosimilars on Market Access
MTE Session: Understanding the Impact of Humira Biosimilars on Market Access
Humira, one of the top-selling drugs in the US, is about to see a slew of competition with seven adalimumab biosimilars approved and set to launch in 2023. We’ll explore how we can expect the market to react and how factors such as launch timing, interchangeability, and contracting will shape the immunology landscape.
MTE Session: MMIT’s FormTrak Integration in Veeva CRM: Smoothing Access to Therapy
MMIT’s FormTrak Integration in Veeva CRM: Smoothing Access to Therapy
Learn how MMIT’s FormTrak tool helps prescribers get their patients on the right therapy even amid complex drug coverage requirements. With FormTrak’s new market access native integration in Veeva CRM, pharma field teams can deliver a consistent and simple access message right in Veeva’s platform.
MTE Session: Access Trends for Innovative Technology Cell and Gene Therapies, Biomarkers, and Telemedicine
Access Trends for Innovative Technology Cell and Gene Therapies, Biomarkers, and Telemedicine
Access barriers to the use of innovative technology such as administrative burden and reimbursement challenges. We will also touch upon payer concern about costs which might be underlying these issues.
MTE Session: Predicting Payer Uptake with Precision
Predicting Payer Uptake with Precision
Learn when and how to select the right analogs to set the most accurate expectations and payer strategy at launch.
MTE Session: Predicting Enrollment Changes in the COVID Era
Predicting Enrollment Changes in the COVID Era
Predicting Enrollment Changes in the COVID Era 2020 was full of uncertainty. But multiple factors in 2021 continue to complicate the payer enrollment landscape, making it challenging to project membership rolls across payers, geographies and channels. We’ll dig into enrollment projections, the drivers behind them and what you can expect from the 2021 payer landscape.
MTE Session: Medical Reimbursement/Billing Challenges Faced by the Market Are Only Growing
Medical Reimbursement/Billing Challenges Faced by the Market Are Only Growing
The number of pricing and coding changes to medically covered drugs is only increasing, and the ways to manage them are constantly evolving. Learn how claims reimbursement is currently being managed, as well as some best practices for leveraging specialty drug data to streamline the process.
MTE Session: Advances in Formulary Management: Integrated Solutions to Optimize Management of Medical and Pharmacy Benefit Drugs
Advances in Formulary Management: Integrated Solutions to Optimize Management of Medical and Pharmacy Benefit Drugs
The continued growth of specialty pharmacy has led to the need to improve management of these complex, high-cost drugs, specifically those covered under the medical benefit. Learn how formularies are currently managed, examine some of the key challenges faced by payers and PBMs, and evaluate new integrated solutions to optimize management of both pharmacy and medically covered drugs.
MTE Session: Tracking Access in Real-Time
Tracking Access in Real-Time
Payer coverage policies continue to become more complex with increasing access hurdles. Changes occur daily and could prevent physicians from prescribing your brand. We’ll dig into ways to sift through the noise and uncover payer account intervention and pull-through opportunities via dashboards and real-time alerts.
MTE Session: Navigating the Complex U.S. Payer Landscape to Grow Your Business
Partner with the industry leader in market access. Gain therapeutic area-specific intel to drive access for your brand.
Psoriasis
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Atopic Dermatitis
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Multiple Sclerosis
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Rheumatoid Arthritis
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Ulcerative Colitis
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Multiple Myeloma
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Crohn's Disease
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Diabetes
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Prostate Cancer
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Acute Myeloid Leukemia
MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.
Non-Small Cell Lung Cancer
View our Market Access Download on NSCLC, with the latest market access findings and trends on prostate cancer therapies.
View data visualizations that illustrate key market access topics and outline successful strategies for moving therapies from pipeline to prescription.
How to Stop Losing Money Due to Inefficient Formulary Verification
Contracting in pharma has grown increasingly complex, which results in significant rebate leakage for manufacturers. Recent MMIT research highlights the severity of the problem.
NDC Mandate Management
RJ Health, an MMIT company, conducted a survey on NDC mandates. In 2016 and 2021, we asked payers questions such as how they are managing NDCs and who performs unit conversions. We compiled these results into an infographic to capture the latest trends in this space. Fill out the form below to see the results.
Analyzing the Patient Journey
Learn how Patient Access Analytics from MMIT and Panalgo can show how coverage decisions influence physician prescriber behavior.
Payer Intelligence Toolkit
You need a variety of resources to develop a successful payer strategy. Download our infographic to learn how MMIT can help your organization.
Briefs that combine in-depth narratives with data-rich charts to provide current insights about a single indication.
Metastatic Melanoma
This excerpt from MMIT’s Metastatic Melanoma Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Non-Small Cell Lung Cancer
This excerpt from MMIT’s Non-Small Cell Lung Cancer Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Bladder Cancer
This excerpt from MMIT’s Bladder Cancer Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Breast Cancer
This excerpt from MMIT’s Breast Cancer Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Orphan Diseases
This excerpt from MMIT’s Orphan Diseases Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Multiple Sclerosis
This excerpt from MMIT’s Multiple Sclerosis Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Rheumatoid Arthritis
This excerpt from MMIT’s Rheumatoid Arthritis Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Colorectal Cancer
This excerpt from MMIT’s Colorectal Cancer Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Multiple Myeloma
This excerpt from MMIT’s Multiple Myeloma Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Prostate Cancer
This excerpt from MMIT’s Prostate Cancer Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Diabetes
This excerpt from MMIT’s Diabetes Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
CAR-T
This excerpt from MMIT’s CAR-T Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Atopic Dermatitis
This excerpt from MMIT’s Atopic Dermatitis Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.
Migraine
This excerpt from MMIT’s Migraine Brief gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.